The primary aim of this study is to examine the effects of co-administered wake therapy followed by light treatment on mood, and secondarily on circadian rhythms, to test the hypothesis that critically-timed chronotherapy improves mood by correcting phase disturbances in melatonin and sleep in women with Premenstrual Dysphoric Disorder.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Treatment-Related Changes from baseline in mood ratings
Timeframe: baseline (month 2) and 1-2 days post intervention (months 3,5)
Treatment-Related Changes from Baseline in Urinary 6-sulfatoxymelatonin (6-SMT)
Timeframe: baseline (month 2) and 1-2 days post intervention (months 3,5)
Treatment-related changes in objective and subjective sleep measures
Timeframe: baseline (month 2) and 1-2 days post intervention (months 3,5)